subject: CHEBI:6801

subject_name: Metformin

object_name: psoriatic arthritis


subject: UMLS:C1314420

subject_name: INJECTION, RASBURICASE, 0.5 MG ADMINISTERED

object_name: tumor lysis syndrome

tested_intervention: unsure


subject: UMLS:C1314420

object_name: Tumor Lysis Syndrome, CTCAE 3.0


subject: UMLS:C1314420

object_name: Tumor Lysis Syndrome, CTCAE 5.0


subject: UMLS:C1314420

object_name: cancer


subject: UMLS:C1314420

object_name: neoplasm


subject: UNII:08GY9K1EUO

subject_name: Rasburicase


subject: UNII:08GY9K1EUO


subject: UNII:08GY9K1EUO


subject: UNII:08GY9K1EUO


subject: UNII:08GY9K1EUO


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UMLS:C1519138

object_name: diffuse large B-cell lymphoma

tested_intervention: yes


subject: CHEMBL.COMPOUND:CHEMBL4298207

subject_name: ZILUCOPLAN

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEMBL.COMPOUND:CHEMBL4298207

object_name: amyotrophic lateral sclerosis


subject: CHEBI:229659

subject_name: Zilucoplan


subject: CHEBI:229659


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Advanced cancer


subject: PUBCHEM.COMPOUND:138684045

object_name: spinal muscular atrophy


subject: PUBCHEM.COMPOUND:138684045

object_name: proximal spinal muscular atrophy


subject: UMLS:C0178555

subject_name: chemical cofactor

object_name: Overweight and obesity


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:32139

object_name: kidney disorder


subject: UMLS:C5669600

subject_name: Ivonescimab

object_name: colorectal adenocarcinoma


subject: UMLS:C0306371

subject_name: Humulin R

object_name: bipolar disorder


subject: UMLS:C0306371

object_name: endogenous depression


subject: UMLS:C0306371

object_name: major depressive disorder


subject: UMLS:C0306371

object_name: Anhedonia


subject: CHEBI:23580

subject_name: decyl group

object_name: filarial elephantiasis


subject: CHEBI:23580

object_name: Lymphadenitis due to Wuchereria bancrofti


subject: CHEBI:23574

subject_name: decanoyl group


subject: CHEBI:23574


subject: CHEBI:16664

subject_name: Albendazole


subject: CHEBI:16664


subject: UMLS:C5670961

subject_name: Copper Cu 64 SAR-bisPSMA

object_name: Non-metastatic prostate cancer


subject: CHEBI:233364

subject_name: Bryostatin

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:233364

object_name: stage IV pancreatic cancer


subject: CHEBI:233364

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:233364

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:233364

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:233364

object_name: Pancreatic carcinoma stage III


subject: CHEBI:233364

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:233364

object_name: pancreatic acinar cell carcinoma


subject: CHEBI:233364

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:88353

subject_name: Bryostatin 1


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: multiple sclerosis


subject: CHEBI:84883

subject_name: Icosapent ethyl

object_name: Heart Disease Risk Factors


subject: CHEBI:84883

object_name: cardiovascular disorder


subject: CHEBI:84883

object_name: Triglyceride increased


subject: CHEBI:84883

object_name: type 2 diabetes mellitus


subject: UniProtKB:Q9WV70

subject_name: NOC2L_MOUSE Nucleolar complex protein 2 homolog (sprot)

object_name: rectal carcinoma


subject: UniProtKB:Q9WV70

object_name: rectal cancer


subject: UniProtKB:Q9WV70

object_name: Childhood Rectal Carcinoma


subject: PR:000011302

subject_name: nucleolar complex protein 2


subject: PR:000011302


subject: PR:000011302


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: CHEBI:133146

subject_name: Phe-Ala


subject: CHEBI:133146


subject: CHEBI:133146


subject: CHEBI:39002

subject_name: perfluoroadamantane


subject: CHEBI:39002


subject: CHEBI:39002


subject: CHEBI:29013

subject_name: Fusidic acid


subject: CHEBI:29013


subject: CHEBI:29013


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:27470


subject: CHEBI:27470


subject: CHEBI:36939

subject_name: Fluorine F-18

object_name: Childhood Breast Carcinoma


subject: CHEBI:36939

object_name: breast carcinoma


subject: CHEBI:36939

object_name: breast cancer


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Urinary incontinence


subject: CHEBI:3160

object_name: Urinary Incontinence, CTCAE 5.0


subject: CHEBI:17026

subject_name: Progesterone

object_name: female infertility


subject: CHEBI:17026

object_name: pregnancy related


subject: UMLS:C1576550

subject_name: Progesterone, Micronized 100 MG Vaginal Kit


subject: UMLS:C1576550


subject: UNII:JUP57A8EPZ

object_name: Her2-receptor negative breast cancer


subject: PUBCHEM.COMPOUND:168346974

subject_name: -Epicatechin

object_name: pulmonary hypertension, primary, 1


subject: PUBCHEM.COMPOUND:168346974

object_name: pulmonary hypertension


subject: PUBCHEM.COMPOUND:168346974

object_name: idiopathic pulmonary arterial hypertension


subject: PUBCHEM.COMPOUND:168346974

object_name: pulmonary arterial hypertension


subject: CHEBI:6801

subject_name: Metformin

object_name: hepatitis A


subject: CHEBI:6801

object_name: hepatitis


subject: UMLS:C0733688

object_name: precursor B-cell acute lymphoblastic leukemia


subject: UMLS:C0733688

object_name: B-cell acute lymphoblastic leukemia


subject: UMLS:C0733688

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C0733688

object_name: B-cell neoplasm


subject: CHEBI:229221

subject_name: Fruquintinib

object_name: Non-clear cell renal cell carcinoma


subject: UMLS:C5847498

subject_name: Irinotecan liposome injection

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:73579

subject_name: Leu-Val


subject: CHEBI:194537

subject_name: Livermorium


subject: UMLS:C1881413

subject_name: Liposome Vesicle


subject: PR:000003915

subject_name: delta-aminolevulinic acid dehydratase


subject: CHEBI:50730

subject_name: Montelukast

object_name: chronic rhinosinusitis with nasal polyps


subject: UMLS:C4053630

subject_name: HCV DNA Vaccine INO-8000


subject: UMLS:C4053630

object_name: Chronic hepatitis


subject: UMLS:C4053630

object_name: hepatitis C


subject: UMLS:C4053630

object_name: liver carcinoma


subject: UNII:91JHE0ANN8

subject_name: Rocakinogene sifuplasmid


subject: UNII:91JHE0ANN8


subject: UNII:91JHE0ANN8


subject: UNII:91JHE0ANN8


subject: MESH:C530986

subject_name: Glucerna


subject: MESH:C530986

object_name: Postoperative Complications


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Transitory tachypnea of newborn


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: ovarian cancer


subject: UNII:K16AIQ8CTM

object_name: ovarian neoplasm


subject: UNII:K16AIQ8CTM

object_name: ovarian carcinoma


subject: CHEBI:9168

subject_name: Sirolimus

object_name: malignant soft tissue neoplasm


subject: CHEBI:9168

object_name: sarcoma


subject: CHEBI:5801

subject_name: Hydroxychloroquine


subject: CHEBI:5801


subject: UNII:4I7U5C459M

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:174615

object_name: inborn error of immunity


subject: CHEBI:28901

subject_name: Busulfan


subject: UMLS:C5392068

subject_name: PD-L1 Inhibitors

object_name: colorectal cancer


subject: UMLS:C5392068

object_name: colorectal carcinoma


subject: UMLS:C5392068

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:6904

subject_name: Metoprolol

object_name: non-traumatic subarachnoid hemorrhage


subject: CHEBI:2955

subject_name: Azithromycin

object_name: Crohn's disease relapse


subject: CHEBI:2955

object_name: biological substance; adverse effect


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: Overweight


subject: CHEBI:31236

object_name: cardiovascular disorder


subject: CHEBI:31236

object_name: hyperlipidemia


subject: CHEBI:31236

object_name: hyperlipoproteinemia


subject: CHEBI:31236

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:31236

object_name: Serum lipids high (finding)


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: Duchenne muscular dystrophy


subject: CHEBI:22586

subject_name: antioxidant

object_name: Inflammation


subject: UMLS:C0003402

subject_name: Antioxidants


subject: CHEMBL.COMPOUND:CHEMBL1200571

subject_name: GADOBENATE DIMEGLUMINE

object_name: Childhood Breast Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: breast cancer


subject: UNII:3Q6PPC19PO


subject: UNII:3Q6PPC19PO


subject: UNII:3Q6PPC19PO


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UNII:7K5O7P6QIU

subject_name: LONCASTUXIMAB

object_name: mantle cell lymphoma


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: unspecified adult solid tumor, protocol specific


subject: GTOPDB:11346

subject_name: vilobelimab

object_name: acute respiratory distress syndrome


subject: GTOPDB:11346

object_name: adult acute respiratory distress syndrome


subject: GTOPDB:11346

object_name: familial acute respiratory distress syndrome, ANLN-related, dog


subject: GTOPDB:11346

object_name: COVID-19-Associated Acute Respiratory Distress Syndrome


subject: UNII:F5T0RF9ZJA


subject: UNII:F5T0RF9ZJA


subject: UNII:F5T0RF9ZJA


subject: UNII:F5T0RF9ZJA


subject: UMLS:C5392705


subject: UMLS:C5392705


subject: UMLS:C5392705


subject: UMLS:C5392705


subject: CHEBI:37845

subject_name: growth hormone

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:37845

object_name: obesity


subject: CHEBI:37845

object_name: Obesity, CTCAE


subject: CHEBI:37845

object_name: Osteopenia


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: PUBCHEM.COMPOUND:170907453


subject: PUBCHEM.COMPOUND:170907453


subject: PUBCHEM.COMPOUND:170907453


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UNII:NQX9KB6PCL


subject: UNII:NQX9KB6PCL


subject: UNII:NQX9KB6PCL


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: UMLS:C0037663


subject: UMLS:C0037663


subject: UMLS:C0037663


subject: PR:000007968

subject_name: somatotropin


subject: PR:000007968


subject: PR:000007968


subject: PR:000007968


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: Hypercholesterolemia


subject: UMLS:C4279276

object_name: EXCESS LMW-DNA


subject: DRUGBANK:DB10640

subject_name: Beet


subject: DRUGBANK:DB10640


subject: DRUGBANK:DB10640


subject: DRUGBANK:DB10640

object_name: metabolic disease


subject: CHEBI:140621

subject_name: Cisatracurium

object_name: Fasciculations


subject: PR:000004274

subject_name: ADP-ribosylation factor-like protein 10

object_name: oral cavity squamous cell carcinoma


subject: PR:000004274

object_name: squamous cell carcinoma of buccal mucosa


subject: PR:000004274

object_name: tongue cancer


subject: CHEBI:84040

object_name: healthy, no evidence of disease


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: ulcerative colitis


subject: CHEBI:60648

object_name: inflammatory bowel disease 1


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: UNII:L500PR95QA


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:94705


subject: CHEBI:94705


subject: CHEBI:9448

subject_name: Terbinafine


subject: CHEBI:9448


subject: UNII:J0FI6WE1QN

subject_name: Casirivimab


subject: CHEBI:47381

subject_name: Diclofenac

object_name: Fetal Death


subject: UMLS:C3896820

subject_name: Anti-Met/EGFR Monoclonal Antibody LY3164530

object_name: Neoplasm Metastasis


subject: UMLS:C3896820

object_name: neoplasm


subject: UMLS:C2347328

subject_name: sirolimus protein-bound particles

object_name: Childhood Malignant Solid Neoplasm


subject: UMLS:C2347328

object_name: Malignant Solid Neoplasm


subject: UMLS:C2347328


subject: UMLS:C2347328

object_name: Childhood Solid Neoplasm


subject: UMLS:C2347328

object_name: Solid Neoplasm


subject: UMLS:C2347328

object_name: Tumor Mass


subject: UMLS:C2347328

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C2347328

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C2347328

object_name: Primary malignant neoplasm


subject: UMLS:C2347328

object_name: childhood malignant neoplasm


subject: UMLS:C2347328

object_name: Malignant obstetric neoplasm


subject: UMLS:C2347328

object_name: situs inversus


subject: UMLS:C2347328

object_name: tuberous sclerosis 1


subject: UMLS:C2347328

object_name: tuberous sclerosis 2


subject: UMLS:C2347328

object_name: tuberous sclerosis


subject: UMLS:C2347328

object_name: metastatic neoplasm


subject: UMLS:C2347328

object_name: Metastasis


subject: UMLS:C2347328

object_name: Metastatic Lesion


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: osteoarthritis


subject: PUBCHEM.COMPOUND:16158207

subject_name: LINACLOTIDE ACETATE

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:16158207

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:16158207

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:16158207

object_name: healthy, no evidence of disease


subject: UNII:NSF067KU1M


subject: UNII:NSF067KU1M


subject: UNII:NSF067KU1M


subject: UNII:NSF067KU1M


subject: UMLS:C2000262

subject_name: MD-1100 acetate


subject: UMLS:C2000262


subject: UMLS:C2000262


subject: UMLS:C2000262


subject: PUBCHEM.COMPOUND:157010089

subject_name: Ferrous ascorbate

object_name: iron deficiency anemia


subject: CHEBI:31607

subject_name: Ferrous fumarate


subject: UMLS:C0722705

subject_name: iron polysaccharide


subject: CHEBI:6073

subject_name: Isradipine

object_name: Parkinson disease


subject: CHEBI:50858

subject_name: corticosteroid

object_name: Brain necrosis


subject: CHEBI:50858

object_name: nasopharyngeal carcinoma


subject: CHEBI:50858

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:50858

object_name: Adverse effect of radiation therapy


subject: CHEBI:50858

object_name: Disorder due to radiotherapy


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: MESH:D000305


subject: MESH:D000305


subject: MESH:D000305


subject: MESH:D000305


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: UMLS:C3536709


subject: UMLS:C3536709


subject: UMLS:C3536709


subject: UMLS:C3536709


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UMLS:C1831768

subject_name: Transdermal Estrogen

object_name: Anorexia


subject: UMLS:C3177398

subject_name: DLBS 1033

object_name: Acute Ischemic Stroke


subject: CHEBI:53351

subject_name: chromium(3+) trichloride

object_name: Alzheimer disease type 1


subject: CHEBI:53351

object_name: Alzheimer disease


subject: CHEBI:53352

subject_name: chromium chloride


subject: CHEBI:53352


subject: UNII:CET32HKA21

subject_name: chromous chloride


subject: UNII:CET32HKA21


subject: UNII:Z310X5O5RP

subject_name: Chromic chloride


subject: UNII:Z310X5O5RP


subject: UMLS:C0300207

object_name: urinary system disorder


subject: CHEBI:144094

subject_name: bicalutamide

object_name: Stage I Prostate Cancer AJCC v6


subject: CHEBI:144094

object_name: Prostate cancer stage I


subject: CHEBI:144094

object_name: Stage I Prostate Cancer AJCC v8


subject: CHEBI:144094

object_name: Stage I Prostate Cancer AJCC v7


subject: CHEBI:144094

object_name: Stage IIA Prostate Cancer AJCC v7


subject: CHEBI:144094

object_name: Stage IIA Prostate Cancer AJCC v8


subject: CHEBI:144094

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:144094

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:144094

object_name: Carcinoma of the prostate stage III


subject: CHEBI:144094

object_name: Stage III Prostate Cancer AJCC v6


subject: CHEBI:144094

object_name: Stage IIB Prostate Cancer AJCC v8


subject: CHEBI:144094

object_name: Stage IIB Prostate Cancer AJCC v7


subject: CHEBI:5523

subject_name: Goserelin


subject: CHEBI:5523


subject: CHEBI:5523


subject: CHEBI:5523


subject: CHEBI:5523


subject: CHEBI:5523


subject: CHEBI:5523


subject: CHEBI:5523


subject: UMLS:C0149473

subject_name: Zoladex


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C1134640

subject_name: Recombinant Fowlpox-Prostate Specific Antigen Vaccine


subject: UMLS:C1134640


subject: UMLS:C1134640


subject: UMLS:C1134640


subject: UMLS:C1134640


subject: UMLS:C1134640


subject: UMLS:C1134640


subject: UMLS:C1134640


subject: UMLS:C1134640


subject: UMLS:C1134640


subject: UMLS:C1134640


subject: UMLS:C1134640


subject: MESH:C439566

subject_name: rV-Tricom


subject: MESH:C439566


subject: MESH:C439566


subject: MESH:C439566


subject: MESH:C439566


subject: MESH:C439566


subject: MESH:C439566


subject: MESH:C439566


subject: MESH:C439566


subject: MESH:C439566


subject: MESH:C439566


subject: MESH:C439566


subject: MESH:C439566

object_name: Prostate cancer recurrent


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C5667119


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8


subject: UMLS:C1832035


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4911

subject_name: Etoposide


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:71417

subject_name: Procarbazine


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: CHEBI:28445

subject_name: vincristine


subject: UMLS:C4520787

subject_name: timolol 5 MG/ML Ophthalmic Solution

object_name: glaucoma


subject: UMLS:C4520787

object_name: Glaucoma, CTCAE


subject: UMLS:C5907958

subject_name: BCR-ABL Inhibitor TGRX-678

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Labor Pain


subject: GTOPDB:8254

subject_name: ozanezumab

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: GTOPDB:8254

object_name: amyotrophic lateral sclerosis


subject: CHEMBL.COMPOUND:CHEMBL2108679

subject_name: OZANEZUMAB


subject: CHEMBL.COMPOUND:CHEMBL2108679


subject: UMLS:C3885499


subject: UMLS:C3885499


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: Irritable heart


subject: PUBCHEM.COMPOUND:3062

object_name: neurocirculatory asthenia


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:4551


subject: CHEBI:8665

subject_name: Pyridostigmine


subject: GTOPDB:4985

object_name: graft versus host disease


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: CHEBI:233453

object_name: varicella zoster infection


subject: CHEBI:35854

subject_name: Valaciclovir


subject: CHEBI:63629

subject_name: Tizanidine

object_name: Spasticity, CTCAE


subject: CHEBI:63629

object_name: Spasticity


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline

object_name: Posterior blepharitis


subject: PUBCHEM.COMPOUND:54671203

object_name: Doxycycline adverse reaction


subject: UMLS:C2830088

object_name: prostate carcinoma


subject: UMLS:C2830088

object_name: prostate cancer


subject: UMLS:C2830088

object_name: Metastatic malignant neoplasm to bone


subject: CHEBI:6121

subject_name: Ketamine

object_name: effects of; anesthesia, spinal and epidural, in pregnancy


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Adynamic bone disease


subject: CHEBI:89324

object_name: Restless legs


subject: CHEBI:89324

object_name: Renal rickets


subject: CHEBI:89324

object_name: end stage renal failure


subject: CHEBI:89324

object_name: Chronic uremia


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UNII:D959AE5USF

subject_name: clofazimine

object_name: leprosy


subject: CHEBI:4325

subject_name: Dapsone


subject: CHEBI:231601

subject_name: trastuzumab

object_name: Metastatic Biliary Tract Carcinoma


subject: CHEBI:231601

object_name: Metastatic Bile Duct Carcinoma


subject: CHEBI:231601

object_name: Unresectable Biliary Tract Carcinoma


subject: CHEBI:231601

object_name: Advanced cancer


subject: CHEBI:231601

object_name: liver carcinoma


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: PUBCHEM.COMPOUND:156768862

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:156768862

object_name: bronchiectasis


subject: CHEBI:61468

subject_name: dimethicone polymer

object_name: Stomach cancer


subject: CHEBI:61468

object_name: gastric cancer


subject: CHEBI:61468

object_name: carcinoma of esophagus


subject: CHEBI:61468

object_name: esophageal cancer


subject: CHEBI:61468

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:61468

object_name: neoplasm of esophagus


subject: CHEBI:31498

subject_name: Simethicone


subject: CHEBI:31498


subject: CHEBI:31498


subject: CHEBI:31498


subject: CHEBI:31498


subject: CHEBI:31498


subject: CHEBI:78002

subject_name: Dimethicone


subject: CHEBI:78002


subject: CHEBI:78002


subject: CHEBI:78002


subject: CHEBI:78002


subject: CHEBI:78002


subject: CHEMBL.COMPOUND:CHEMBL2108476

subject_name: PRONASE


subject: CHEMBL.COMPOUND:CHEMBL2108476


subject: CHEMBL.COMPOUND:CHEMBL2108476


subject: CHEMBL.COMPOUND:CHEMBL2108476


subject: CHEMBL.COMPOUND:CHEMBL2108476


subject: CHEMBL.COMPOUND:CHEMBL2108476


subject: UMLS:C0033417

subject_name: Pronase


subject: UMLS:C0033417


subject: UMLS:C0033417


subject: UMLS:C0033417


subject: UMLS:C0033417


subject: UMLS:C0033417


subject: PUBCHEM.COMPOUND:140529927

subject_name: Magnesium threonate

object_name: osteoarthritis, knee


subject: UMLS:C3661433

subject_name: magnesium threonate


subject: CHEBI:31705

subject_name: Iodixanol

object_name: coronary artery disorder


subject: CHEBI:31705

object_name: coronary atherosclerosis


subject: PUBCHEM.COMPOUND:3222

object_name: arteriosclerosis disorder


subject: PUBCHEM.COMPOUND:3222

object_name: atherosclerosis


subject: CHEBI:4784

subject_name: Enalapril


subject: CHEBI:4784


subject: CHEBI:188851

subject_name: Muraglitazar

object_name: type 2 diabetes mellitus


subject: UMLS:C1568490

subject_name: muraglitazar


subject: UNII:45X7OU8C4J

subject_name: DOMVANALIMAB

object_name: lung cancer


subject: UNII:45X7OU8C4J

object_name: lung neoplasm


subject: UNII:45X7OU8C4J

object_name: lung carcinoma


subject: UNII:45X7OU8C4J

object_name: non-small cell lung carcinoma


subject: UNII:45X7OU8C4J

object_name: non-small cell squamous lung carcinoma


subject: UMLS:C5206853

subject_name: Domvanalimab


subject: UMLS:C5206853


subject: UMLS:C5206853


subject: UMLS:C5206853


subject: UMLS:C5206853


subject: GTOPDB:12349

subject_name: zimberelimab


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: MESH:D056692

subject_name: Prebiotics

object_name: pervasive developmental disorder


subject: MESH:D056692

object_name: autism


subject: CHEBI:188197

object_name: prolymphocytic leukemia


subject: CHEBI:188197

object_name: Chronic lymphocytic leukaemia stage 4


subject: CHEBI:188197

object_name: Chronic lymphocytic leukaemia stage 3


subject: CHEBI:188197

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:188197

object_name: ISS Stage III Plasma Cell Myeloma


subject: CHEBI:188197

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:188197

object_name: Plasma cell myeloma refractory


subject: CHEBI:188197

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:188197

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:188197

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:188197

object_name: testicular lymphoma


subject: CHEBI:188197

object_name: intraocular lymphoma


subject: CHEBI:188197

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: CHEBI:188197

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: CHEBI:188197

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:188197

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:188197

object_name: anaplastic large cell lymphoma


subject: CHEBI:188197

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: CHEBI:188197

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:188197

object_name: Adult T-cell lymphoma/leukaemia stage III


subject: CHEBI:188197

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:188197

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:188197

object_name: Mantle cell lymphoma stage III


subject: CHEBI:188197

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:188197

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:188197

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:188197

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:188197

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:188197

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:188197

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:188197

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: CHEBI:188197

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:188197

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: CHEBI:188197

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:188197

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:188197

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:188197

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: CHEBI:188197

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:188197

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:188197

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:188197

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: CHEBI:188197

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:188197

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:188197

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:188197

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:188197

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:188197

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:188197

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:188197

object_name: MALT lymphoma


subject: CHEBI:188197

object_name: Stage IV Adult Hodgkin Lymphoma


subject: CHEBI:188197

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:188197

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:188197

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:188197

object_name: Stage III Adult Hodgkin Lymphoma


subject: CHEBI:188197

object_name: Stage III Adult Burkitt Lymphoma


subject: CHEBI:188197

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:188197

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:188197

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:188197

object_name: Marginal zone lymphoma stage III


subject: CHEBI:188197

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:188197

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:188197

object_name: Cutaneous T-cell lymphoma stage IV


subject: CHEBI:188197

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:188197

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:188197

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:188197

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:188197

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:188197

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:188197


subject: CHEBI:188197

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:188197

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: CHEBI:188197

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:7936

subject_name: Paroxetine

object_name: hepatitis C


subject: CHEBI:7936

object_name: chronic hepatitis C virus infection


subject: PUBCHEM.COMPOUND:53387035

subject_name: Pradigastat

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:53387035

object_name: coronary atherosclerosis


subject: PUBCHEM.COMPOUND:53387035

object_name: hypertriglyceridemia


subject: PUBCHEM.COMPOUND:53387035

object_name: Hypertriglyceridemia, CTCAE


subject: UNII:2U23G6VNUZ


subject: UNII:2U23G6VNUZ


subject: UNII:2U23G6VNUZ


subject: UNII:2U23G6VNUZ


subject: UMLS:C4045958


subject: UMLS:C4045958


subject: UMLS:C4045958


subject: UMLS:C4045958


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: abdomen; wound, abdominal wall


subject: CHEBI:231324

subject_name: alpelisib

object_name: Refractory Breast Carcinoma


subject: CHEBI:231324

object_name: triple-negative breast carcinoma


subject: CHEBI:231324

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:231324

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:231324

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:231324

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:231324

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:231324

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:231324

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:231324

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:231324

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:231324

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:231324

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:231324

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:231324

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:231324

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:231324

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:231324

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:231324

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:231324

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:231324

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: Refractory Breast Carcinoma


subject: MESH:C520255

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: MESH:C520255

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: MESH:C520255

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: MESH:C520255

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: MESH:C520255

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: MESH:C520255

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: MESH:C520255

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: MESH:C520255

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: MESH:C520255

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: MESH:C520255

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: MESH:C520255

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: MESH:C520255

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: triple-negative breast carcinoma


subject: UMLS:C3658854


subject: CHEBI:46662

subject_name: mineral

object_name: telogen effluvium


subject: MESH:D010936

subject_name: Plant Extracts


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab

object_name: inflammatory bowel disease


subject: UNII:9RV78Q2002

subject_name: Vedolizumab

object_name: psoriasis


subject: UNII:9RV78Q2002


subject: UMLS:C1098513


subject: UMLS:C1098513


subject: MESH:C000613148

object_name: Androgen excess


subject: MESH:C000613148

object_name: type 2 diabetes mellitus


subject: MESH:C000613148

object_name: Insulin resistance


subject: UMLS:C5787295

subject_name: ACR 368

object_name: head and neck squamous cell carcinoma


subject: CHEBI:132967

subject_name: Elbasvir

object_name: liver failure


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib

object_name: Locally advanced breast cancer


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: Myelodysplasia


subject: CHEBI:141969

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:141969

object_name: childhood myelodysplastic syndrome


subject: CHEBI:141969

object_name: Myelodysplastic Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: UMLS:C1174783

subject_name: Zarnestra


subject: UMLS:C1174783


subject: UMLS:C1174783


subject: UMLS:C1174783


subject: UMLS:C0393031


subject: UMLS:C0393031


subject: UMLS:C0393031


subject: UMLS:C0393031


subject: CHEBI:31355

subject_name: Carboplatin

object_name: female breast carcinoma


subject: CHEBI:45863


subject: CHEBI:71219

subject_name: Pazopanib

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:71219

object_name: Malignant neoplasm of female breast


subject: CHEBI:71219


subject: UMLS:C4079746

object_name: fibromyalgia


subject: UMLS:C4079746

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UMLS:C4079746


subject: CHEBI:7773

subject_name: Ondansetron

object_name: hypotension


subject: CHEBI:7773

object_name: Hypotension, CTCAE


subject: CHEBI:7773

object_name: Shivering


subject: PUBCHEM.COMPOUND:4442

subject_name: Ramosetron


subject: PUBCHEM.COMPOUND:4442


subject: PUBCHEM.COMPOUND:4442

object_name: Nausea and vomiting


subject: PUBCHEM.COMPOUND:4442


subject: UMLS:C1696294

subject_name: Yaz

object_name: acne


subject: CHEBI:7824

subject_name: Oxcarbazepine

object_name: bipolar disorder


subject: CHEBI:4046

subject_name: Cyproheptadine

object_name: Ischaemic mitral regurgitation


subject: CHEBI:38940

subject_name: Sunitinib

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:38940

object_name: pancreatic acinar cell carcinoma


subject: CHEBI:231951

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:231951

object_name: obesity


subject: CHEBI:231951

object_name: Obesity, CTCAE


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:38545


subject: CHEBI:38545


subject: CHEBI:36704

subject_name: Imiquimod

object_name: Basal cell carcinoma, cutaneous


subject: CHEBI:50648

subject_name: Alitretinoin

object_name: liver failure


subject: UMLS:C0302908

subject_name: Liquid substance

object_name: Iron deficiency


subject: UMLS:C0302908

object_name: iron deficiency anemia


subject: CHEBI:12777

subject_name: Vitamin A


subject: CHEBI:12777


subject: UNII:958AQ7B6R1

subject_name: Eprotirome

object_name: Primary hypercholesterolemia


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: carcinoma


subject: CHEBI:85994

object_name: Epithelioma


subject: GTOPDB:1160

subject_name: hCG

object_name: hypogonadism, male


subject: GTOPDB:1160

object_name: hypogonadotropic hypogonadism


subject: GTOPDB:1160

object_name: Klinefelter syndrome


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)


subject: CHEBI:81570


subject: CHEBI:81570


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C0309130


subject: UMLS:C0309130


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: UMLS:C1141639


subject: UMLS:C1141639


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: primary antiphospholipid syndrome


subject: UMLS:C4287651

subject_name: Quadrivalent Inactivated Influenza Vaccine


subject: UMLS:C4318638

subject_name: Quadrivalent Influenza Vaccine


subject: DRUGBANK:DB15844

subject_name: CVnCoV


subject: UMLS:C2740325

subject_name: Xiaflex

object_name: Dupuytren's disease of finger


subject: CHEBI:135622

subject_name: Besifloxacin

object_name: reported history of cataract surgery


subject: CHEBI:63611

subject_name: Moxifloxacin


subject: CHEBI:8382

subject_name: Prednisone

object_name: Crohn disease


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: Autoimmunity


subject: CHEBI:17754

subject_name: Glycerin

object_name: bacterial meningitis


subject: CHEBI:46195

subject_name: Acetaminophen


subject: UMLS:C0051821

subject_name: andrographolide

object_name: mild neurocognitive disorder


subject: UMLS:C4085979

object_name: Klatskin Tumor


subject: UMLS:C4287707

subject_name: Cdk4/6 inhibitor shr6390

object_name: non-small cell lung carcinoma


subject: UMLS:C4287707

object_name: liver carcinoma


subject: UMLS:C4287707


subject: UMLS:C4287707

object_name: colorectal cancer


subject: UMLS:C4287707

object_name: colorectal carcinoma


subject: UMLS:C1977391

subject_name: atazanavir, ritonavir drug combination

object_name: HIV infection


subject: UMLS:C1950497

subject_name: optive

object_name: dry eye syndrome


subject: UMLS:C1950497

object_name: Dry Eye, CTCAE


subject: UMLS:C1950497

object_name: Dryness of eye


subject: UMLS:C1655274

subject_name: Systane


subject: UMLS:C1655274


subject: UMLS:C1655274


subject: UMLS:C3827055

object_name: B-cell neoplasm


subject: UMLS:C3827055

object_name: T-Cell Lymphoma


subject: UMLS:C3827055

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:71952

subject_name: Dactolisib

object_name: Malignant Solid Neoplasm


subject: UMLS:C2347425


subject: UNII:HOY74VZE0M

subject_name: gadoxetate

object_name: Benign neoplasm of liver


subject: UNII:HOY74VZE0M

object_name: Liver problem


subject: UMLS:C0675788

subject_name: Eovist


subject: UMLS:C0675788


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: neurotoxicity


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C0720492

subject_name: Fluzone

object_name: influenza


subject: CHEBI:3213

subject_name: Bumetanide

object_name: Unresectable Hepatocellular Carcinoma


subject: GTOPDB:8294

subject_name: lampalizumab

object_name: Geographic atrophy


subject: UNII:UWU93Y99R3


subject: UMLS:C2983764

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:231693

subject_name: Capmatinib


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Suicide


subject: CHEBI:28939

object_name: Self-Injury


subject: CHEBI:28939

object_name: Self-injurious behavior


subject: UMLS:C5787220

subject_name: HM15211 (LONG-ACTING GLP-1/GIP/GLUCAGON TRIPLE AGONIST)

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:91899

object_name: Intubation complication


subject: CHEBI:3207

subject_name: Budesonide


subject: PUBCHEM.COMPOUND:2269


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: DRUGBANK:DB10394

subject_name: Phleum pratense pollen

object_name: Atopic rhinitis


subject: DRUGBANK:DB10394

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Clinical Stage I Gastric Cancer AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage IB Gastric Cancer AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage II Gastric Cancer AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31348

object_name: Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31348

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31348

object_name: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31348

object_name: Clinical Stage II Gastric Cancer AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage IIB Gastric Cancer AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage III Gastric Cancer AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage IIA Gastric Cancer AJCC v8


subject: CHEBI:31348

object_name: Clinical Stage IIB Gastric Cancer AJCC v8


subject: CHEBI:31348

object_name: Clinical Stage IIA Gastric Cancer AJCC v8


subject: CHEBI:31348

object_name: Clinical Stage III Gastric Cancer AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage IIIC Gastric Cancer AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage IIIB Gastric Cancer AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage IIIA Gastric Cancer AJCC v8


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Clinical Stage I Gastric Cancer AJCC v8


subject: CHEBI:4672

object_name: Pathologic Stage IB Gastric Cancer AJCC v8


subject: CHEBI:4672

object_name: Pathologic Stage II Gastric Cancer AJCC v8


subject: CHEBI:4672

object_name: Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4672

object_name: Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4672

object_name: Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4672

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4672

object_name: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4672

object_name: Clinical Stage II Gastric Cancer AJCC v8


subject: CHEBI:4672

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4672

object_name: Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4672

object_name: Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4672

object_name: Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4672

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4672

object_name: Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4672

object_name: Pathologic Stage IIB Gastric Cancer AJCC v8


subject: CHEBI:4672

object_name: Pathologic Stage III Gastric Cancer AJCC v8


subject: CHEBI:4672

object_name: Pathologic Stage IIA Gastric Cancer AJCC v8


subject: CHEBI:4672

object_name: Clinical Stage IIB Gastric Cancer AJCC v8


subject: CHEBI:4672

object_name: Clinical Stage IIA Gastric Cancer AJCC v8


subject: CHEBI:4672

object_name: Clinical Stage III Gastric Cancer AJCC v8


subject: CHEBI:4672

object_name: Pathologic Stage IIIC Gastric Cancer AJCC v8


subject: CHEBI:4672

object_name: Pathologic Stage IIIB Gastric Cancer AJCC v8


subject: CHEBI:4672

object_name: Pathologic Stage IIIA Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Pathologic Stage II Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Clinical Stage II Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid

object_name: Clinical Stage I Gastric Cancer AJCC v8


subject: CHEBI:191174

object_name: Pathologic Stage IB Gastric Cancer AJCC v8


subject: CHEBI:191174


subject: CHEBI:191174

object_name: Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:191174

object_name: Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:191174

object_name: Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:191174

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:191174

object_name: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:191174


subject: CHEBI:191174

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:191174

object_name: Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:191174

object_name: Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:191174

object_name: Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:191174

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:191174

object_name: Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:191174

object_name: Pathologic Stage IIB Gastric Cancer AJCC v8


subject: CHEBI:191174

object_name: Pathologic Stage III Gastric Cancer AJCC v8


subject: CHEBI:191174

object_name: Pathologic Stage IIA Gastric Cancer AJCC v8


subject: CHEBI:191174

object_name: Clinical Stage IIB Gastric Cancer AJCC v8


subject: CHEBI:191174

object_name: Clinical Stage IIA Gastric Cancer AJCC v8


subject: CHEBI:191174

object_name: Clinical Stage III Gastric Cancer AJCC v8


subject: CHEBI:191174

object_name: Pathologic Stage IIIC Gastric Cancer AJCC v8


subject: CHEBI:191174

object_name: Pathologic Stage IIIB Gastric Cancer AJCC v8


subject: CHEBI:191174

object_name: Pathologic Stage IIIA Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid

object_name: Clinical Stage I Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Pathologic Stage IB Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Pathologic Stage II Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Clinical Stage II Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Pathologic Stage IIB Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Pathologic Stage III Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Pathologic Stage IIA Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Clinical Stage IIB Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Clinical Stage IIA Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Clinical Stage III Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Pathologic Stage IIIC Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Pathologic Stage IIIB Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: Pathologic Stage IIIA Gastric Cancer AJCC v8


subject: CHEBI:15640

subject_name: Leucovorin

object_name: Clinical Stage I Gastric Cancer AJCC v8


subject: CHEBI:15640

object_name: Pathologic Stage IB Gastric Cancer AJCC v8


subject: CHEBI:15640

object_name: Pathologic Stage II Gastric Cancer AJCC v8


subject: CHEBI:15640

object_name: Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:15640

object_name: Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:15640

object_name: Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:15640

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:15640

object_name: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:15640

object_name: Clinical Stage II Gastric Cancer AJCC v8


subject: CHEBI:15640

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:15640

object_name: Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:15640

object_name: Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:15640

object_name: Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:15640

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:15640

object_name: Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:15640

object_name: Pathologic Stage IIB Gastric Cancer AJCC v8


subject: CHEBI:15640

object_name: Pathologic Stage III Gastric Cancer AJCC v8


subject: CHEBI:15640

object_name: Pathologic Stage IIA Gastric Cancer AJCC v8


subject: CHEBI:15640

object_name: Clinical Stage IIB Gastric Cancer AJCC v8


subject: CHEBI:15640

object_name: Clinical Stage IIA Gastric Cancer AJCC v8


subject: CHEBI:15640

object_name: Clinical Stage III Gastric Cancer AJCC v8


subject: CHEBI:15640

object_name: Pathologic Stage IIIC Gastric Cancer AJCC v8


subject: CHEBI:15640

object_name: Pathologic Stage IIIB Gastric Cancer AJCC v8


subject: CHEBI:15640

object_name: Pathologic Stage IIIA Gastric Cancer AJCC v8


subject: CHEBI:63606

subject_name: Levoleucovorin

object_name: Clinical Stage I Gastric Cancer AJCC v8


subject: CHEBI:63606

object_name: Pathologic Stage IB Gastric Cancer AJCC v8


subject: CHEBI:63606

object_name: Pathologic Stage II Gastric Cancer AJCC v8


subject: CHEBI:63606

object_name: Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:63606

object_name: Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:63606

object_name: Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:63606

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:63606

object_name: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:63606

object_name: Clinical Stage II Gastric Cancer AJCC v8


subject: CHEBI:63606

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:63606

object_name: Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:63606

object_name: Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:63606

object_name: Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:63606

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:63606

object_name: Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:63606

object_name: Pathologic Stage IIB Gastric Cancer AJCC v8


subject: CHEBI:63606

object_name: Pathologic Stage III Gastric Cancer AJCC v8


subject: CHEBI:63606

object_name: Pathologic Stage IIA Gastric Cancer AJCC v8


subject: CHEBI:63606

object_name: Clinical Stage IIB Gastric Cancer AJCC v8


subject: CHEBI:63606

object_name: Clinical Stage IIA Gastric Cancer AJCC v8


subject: CHEBI:63606

object_name: Clinical Stage III Gastric Cancer AJCC v8


subject: CHEBI:63606

object_name: Pathologic Stage IIIC Gastric Cancer AJCC v8


subject: CHEBI:63606

object_name: Pathologic Stage IIIB Gastric Cancer AJCC v8


subject: CHEBI:63606

object_name: Pathologic Stage IIIA Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: Pathologic Stage II Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Clinical Stage II Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:3077

subject_name: Betamethasone

object_name: psoriasis vulgaris


subject: CHEBI:74224

object_name: cancer


subject: CHEBI:74224

object_name: neoplasm


subject: CHEBI:27514

subject_name: genistin


subject: CHEBI:27514


subject: CHEBI:28088

subject_name: Genistein


subject: CHEBI:28088


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: cataract


subject: UNII:2S9ZZM9Q9V

object_name: Cataract, CTCAE 3.0


subject: UNII:2S9ZZM9Q9V

object_name: Cataract, CTCAE 5.0


subject: UNII:2S9ZZM9Q9V

object_name: cataract on exam (physical finding)


subject: UNII:2S9ZZM9Q9V

object_name: diabetes mellitus


subject: UNII:2S9ZZM9Q9V

object_name: cystoid macular edema


subject: CHEBI:240107

subject_name: Bromfenac


subject: CHEBI:240107


subject: CHEBI:41879

subject_name: Dexamethasone


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog


subject: PUBCHEM.COMPOUND:633097


subject: PUBCHEM.COMPOUND:633097


subject: PUBCHEM.COMPOUND:633097


subject: PUBCHEM.COMPOUND:633097


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:9667


subject: CHEBI:9667


subject: CHEBI:9667


subject: CHEBI:9667


subject: UNII:H4C81M8YYW

object_name: chronic pain (diagnosis)


subject: UNII:H4C81M8YYW

object_name: Chronic pain


subject: UNII:H4C81M8YYW

object_name: Acute Pain


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: castration-resistant prostate carcinoma


subject: UNII:52CMI0WC3Y

object_name: Stage IV Prostate Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IVB Prostate Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IVA Prostate Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Adenocarcinoma of the prostate metastatic


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:72317

subject_name: Cabozantinib


subject: CHEBI:72317


subject: CHEBI:72317


subject: UMLS:C2932376

subject_name: XOMA 052

object_name: type 1 diabetes mellitus


subject: CHEBI:8707

subject_name: Quetiapine

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:8707

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:8707

object_name: morbid obesity


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Chronic lymphocytic leukaemia stage 1


subject: PUBCHEM.COMPOUND:131769963

object_name: Chronic lymphocytic leukaemia stage 2


subject: PUBCHEM.COMPOUND:131769963

object_name: Chronic lymphocytic leukaemia stage 4


subject: PUBCHEM.COMPOUND:131769963

object_name: Chronic lymphocytic leukaemia stage 3


subject: PUBCHEM.COMPOUND:131769963

object_name: Chronic lymphocytic leukaemia refractory


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:74705

subject_name: Met-Leu

object_name: acoustic neuroma


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UMLS:C3485429

subject_name: Probiotic Formula

object_name: Therapy Object (animal model)


subject: UMLS:C3485429

object_name: diverticulitis of colon


subject: CHEBI:24433

subject_name: group

object_name: Lower urinary tract infectious disease


subject: UMLS:C0042210

subject_name: Vaccines

object_name: HPV-associated cervical carcinoma


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5235868

object_name: colorectal cancer


subject: UMLS:C5235868

object_name: colorectal carcinoma


subject: UMLS:C4745029

subject_name: HLX 10


subject: UMLS:C4745029


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: Severe asthma


subject: UNII:913P6LK81M

subject_name: Doravirine

object_name: HIV infection


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: Adult Angiosarcoma


subject: CHEBI:68646

object_name: stage III adult soft tissue sarcoma


subject: CHEBI:68646

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: CHEBI:68646

object_name: Stage IV adult soft tissue sarcoma


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:75929

object_name: substance-related disorder


subject: CHEBI:40009

subject_name: Cycloserine


subject: CHEBI:15367

subject_name: Tretinoin

object_name: squamous cell carcinoma


subject: CHEBI:15367

object_name: basal cell carcinoma


subject: CHEBI:15367

object_name: skin basal cell carcinoma


subject: CHEBI:15367

object_name: skin neoplasm


subject: CHEBI:9927

subject_name: Valsartan

object_name: inherited lipid metabolism disorder


subject: CHEBI:9927

object_name: Dyslipidemia


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: hypertension


subject: CHEBI:38545

object_name: Hypertension, CTCAE


subject: CHEBI:36791

subject_name: Escitalopram

object_name: asthma


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:50733

subject_name: nutraceutical

object_name: prostate carcinoma


subject: CHEBI:50733

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Hepatic ascites


subject: GTOPDB:7385

subject_name: catumaxomab

object_name: bladder tumor


subject: UNII:M2HPV837HO


subject: UMLS:C1831854


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: cocaine abuse


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: background diabetic retinopathy


subject: CHEBI:66910

subject_name: Axitinib

object_name: metastatic melanoma


subject: CHEBI:66910

object_name: gastric neoplasm


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Nutritional status


subject: PR:000004904

subject_name: complement C5


subject: UMLS:C4331365

subject_name: Sustained-Exposure Dexamethasone Formulation OTO-104

object_name: Meniere disease


subject: PUBCHEM.COMPOUND:11957664

subject_name: PIRIBEDIL

object_name: Parkinson disease


subject: CHEBI:92833

subject_name: Piribedil


subject: UMLS:C5417944

subject_name: Anti-PD-1 Monoclonal Antibody 609A

object_name: Solid Neoplasm


subject: GTOPDB:10067

object_name: Hodgkin Disease


subject: GTOPDB:10067

object_name: Adult Hodgkin Lymphoma


subject: GTOPDB:10067

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C2986404


subject: UMLS:C2986404


subject: UMLS:C2986404


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Childhood Solid Neoplasm


subject: CHEBI:52717

object_name: Adult Solid Neoplasm


subject: CHEBI:52717


subject: CHEBI:52717

object_name: carcinoma of urethra


subject: CHEBI:52717

object_name: urethra cancer


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:22586

subject_name: antioxidant

object_name: chronic pancreatitis


subject: UMLS:C0003402

subject_name: Antioxidants


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEMBL.COMPOUND:CHEMBL1909054

subject_name: CARBOXYMETHYLCELLULOSE

object_name: dry eye syndrome


subject: PUBCHEM.COMPOUND:57503849

subject_name: Hydroxypropylmethylcellulose


subject: UNII:B1QE5P712K

subject_name: hypromellose 2208 (100 MPA.S)


subject: CHEBI:7773

subject_name: Ondansetron

object_name: schizophrenia


subject: CHEBI:7773

object_name: Schizoaffective and schizophreniform disorders


subject: CHEBI:30884

subject_name: glycoloyl group

object_name: intrahepatic cholangiocarcinoma


subject: CHEBI:73890

subject_name: Gly-Cys


subject: UNII:9927MT646M

subject_name: Basiliximab

object_name: cytokine release syndrome


subject: UNII:9927MT646M

object_name: Cytokine storm


subject: UNII:9927MT646M


subject: UNII:9927MT646M

object_name: SARS-CoV-2 acute respiratory disease


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: brain injury


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: migraine


subject: CHEBI:41879

object_name: migraine with or without aura, susceptibility to, 1


subject: UMLS:C2002939

object_name: Childhood Breast Carcinoma


subject: UMLS:C2002939

object_name: breast carcinoma


subject: UMLS:C2002939

object_name: breast cancer


subject: CHEBI:7640

subject_name: Nortriptyline

object_name: idiopathic gastroparesis


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Missed abortion


subject: UMLS:C0592155

subject_name: Syntocinon


subject: MESH:C000632500

subject_name: reolysin

object_name: head and neck squamous cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2107867

subject_name: CENPLACEL-L

object_name: Acute Stroke


subject: CHEMBL.COMPOUND:CHEMBL2107867

object_name: middle cerebral artery infarction


subject: CHEMBL.COMPOUND:CHEMBL2107867

object_name: posterior cerebral artery infarction


subject: MESH:C000623078

object_name: irritable bowel syndrome


subject: UMLS:C5854482

subject_name: Anti-CTLA-4 Monoclonal Antibody KD6001

object_name: melanoma


subject: GTOPDB:12989

subject_name: toripalimab


subject: UNII:8JXN261VVA


subject: PR:000005931

object_name: Cirrhosis


subject: PR:000005931

object_name: liver cirrhosis


subject: CHEBI:144903

subject_name: Pro-Arg-Pro


subject: CHEBI:144903

object_name: anosmia


subject: CHEBI:144903

object_name: Anosmia, CTCAE


subject: CHEBI:61848


subject: CHEBI:61848


subject: CHEBI:61848


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: UniProtKB:P05142


subject: UniProtKB:P05142


subject: PR:000013551


subject: PR:000013551


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: PR:000003551


subject: PR:000003551


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: UniProtKB:P67986


subject: UniProtKB:P67986


subject: PR:000001886

subject_name: major prion protein


subject: PR:000001886


subject: PR:000001886


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000030465


subject: PR:000030465


subject: PR:000013555

subject_name: proline-rich protein 2


subject: PR:000013555


subject: PR:000013555


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: UniProtKB:P05143


subject: UniProtKB:P05143


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PR:000032963


subject: PR:000032963


subject: CHEBI:16796

subject_name: Melatonin

object_name: traumatic encephalopathy


subject: CHEBI:93775

subject_name: Amethopterin

object_name: cardiovascular disorder


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UMLS:C3896797

object_name: metastatic colorectal cancer


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: Disseminated Malignant Neoplasm


subject: UNII:6XC1PAD3KF

object_name: Embolism, Tumor


subject: UNII:6XC1PAD3KF

object_name: Neoplasm Metastasis


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Endometrioma


subject: CHEBI:28939

object_name: female infertility


subject: CHEBI:9150

subject_name: Simvastatin

object_name: EXCESS LMW-DNA


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Metastatic malignant neoplasm to bone


subject: CHEBI:5801

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:3374

subject_name: Capsaicin

object_name: neuralgia


subject: CHEBI:3374

object_name: Neuropathic pain


subject: CHEBI:9139

subject_name: Sildenafil

object_name: Liver Fibrosis


subject: UMLS:C0770246

subject_name: PROTEIN SUPPLEMENTS

object_name: Light for dates


subject: UMLS:C0770246

object_name: Growth delay


subject: UMLS:C0770246

object_name: Failure to Thrive


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: NK/T-cell lymphoma, nasal and nasal-type


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:4911

subject_name: Etoposide


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: infertility


subject: MESH:D007252

subject_name: Influenza Vaccines


subject: UMLS:C5395271

subject_name: Vaccine product containing only Influenza virus antigen (medicinal product)


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: Masked Hypertension


subject: PUBCHEM.COMPOUND:155543961

object_name: Overweight


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: CHEBI:135349

subject_name: Mitiglinide


subject: CHEBI:135349

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:135349

object_name: obesity


subject: CHEBI:135349

object_name: Obesity, CTCAE


subject: CHEBI:135349


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:17549

object_name: Recurrent Glioblastoma


subject: CHEBI:17549

object_name: Brain Stem Glioblastoma


subject: CHEBI:17549

object_name: glioma susceptibility 1


subject: CHEBI:125427

object_name: opiate dependence


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:27470

subject_name: Folic acid

object_name: folic acid deficiency anemia


subject: CHEBI:27470

object_name: thalassemia


subject: UMLS:C0721591

subject_name: Materna


subject: UMLS:C0721591


subject: CHEBI:305790

subject_name: thyroxine

object_name: Recurrence


subject: CHEBI:305790

object_name: Recurrent Malignant Neoplasm


subject: CHEBI:305790

object_name: Recurrent disease


subject: CHEBI:305790

object_name: Recurrent tumor


subject: CHEBI:305790

object_name: thyroid tumor


subject: CHEBI:305790

object_name: thyroid gland carcinoma


subject: CHEBI:305790

object_name: thyroid cancer


subject: CHEBI:305790

object_name: Surgical procedure finding


subject: CHEBI:18332

subject_name: Levothyroxine


subject: CHEBI:18332


subject: CHEBI:18332


subject: CHEBI:18332


subject: CHEBI:18332


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: IgG4-related retroperitoneal fibrosis


subject: UNII:4F4X42SYQ6

object_name: autoimmune pancreatitis


subject: UNII:4F4X42SYQ6

object_name: sialadenitis


subject: UNII:4F4X42SYQ6

object_name: Pseudotumor


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:63612

subject_name: Nelarabine

object_name: leukemia


subject: CHEBI:63612

object_name: childhood leukemia


subject: CHEBI:63612

object_name: Oral Complication


subject: CHEBI:63612

object_name: mucositis


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UNII:4SED7F4BSG

subject_name: Cipaglucosidase alfa

object_name: Pompe's disease adult onset


subject: UNII:4SED7F4BSG

object_name: glycogen storage disease due to acid maltase deficiency, late-onset


subject: CHEBI:50381

subject_name: Miglustat


subject: CHEBI:50381


subject: CHEBI:6067

subject_name: Isotretinoin


subject: CHEBI:6067


subject: PUBCHEM.COMPOUND:5470

subject_name: tibolone

object_name: Depression perimenopausal


subject: UMLS:C4305969

object_name: benign prostatic hyperplasia


subject: UMLS:C0724588

subject_name: Recombinant Follicle Stimulating Hormone

object_name: Unexplained infertility


subject: CHEBI:8499

subject_name: Propranolol

object_name: mortality


subject: CHEMBL.COMPOUND:CHEMBL4650292

object_name: melanoma


subject: UMLS:C3827106


subject: UMLS:C1648631

subject_name: L-Tyrosine 500 mg

object_name: Stress


subject: CHEBI:5613

subject_name: Haloperidol

object_name: Vomiting, CTCAE


subject: CHEBI:5613

object_name: Vomiting


subject: CHEBI:5613

object_name: Nausea, CTCAE_5


subject: CHEBI:5613

object_name: Nausea


subject: CHEBI:5613

object_name: Nausea, CTCAE_3


subject: UNII:N824AOU5XV

subject_name: Pegvisomant

object_name: pituitary gland disorder


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: osteoarthritis, knee


subject: CHEBI:73604

object_name: Childhood Breast Carcinoma


subject: CHEBI:73604

object_name: breast carcinoma


subject: CHEBI:73604

object_name: breast cancer


subject: CHEBI:135207

subject_name: Clofedanol

object_name: transient ischemic attack


subject: CHEBI:135207

object_name: stroke disorder


subject: CHEBI:135207

object_name: cerebrovascular disorder


subject: CHEBI:135207

object_name: Stroke (heart beat)


subject: CHEBI:135207

object_name: Stroke, CTCAE


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:31186

subject_name: Alfacalcidol

object_name: pelvic organ prolapse


subject: GTOPDB:13396

subject_name: ivonescimab

object_name: pancreatic neoplasm


subject: GTOPDB:13396

object_name: exocrine pancreatic carcinoma


subject: GTOPDB:13396

object_name: malignant pancreatic neoplasm


subject: UNII:Y0O332CU66

subject_name: IVONESCIMAB


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UMLS:C5447482

subject_name: Ligufalimab


subject: UMLS:C5447482


subject: UMLS:C5447482


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: ST-elevation myocardial infarction


subject: CHEBI:39548

subject_name: Atorvastatin


subject: CHEBI:35176

subject_name: Zinc sulfate

object_name: diarrhea


subject: CHEBI:35176

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:35176

object_name: Diarrhea, CTCAE


subject: CHEBI:35176

object_name: gastroenteritis


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Plaque induced gingival disease


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: UMLS:C2827680

subject_name: Vinorelbine Tartrate Oral

object_name: Childhood Breast Carcinoma


subject: UMLS:C2827680

object_name: breast carcinoma


subject: UMLS:C2827680

object_name: breast cancer


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: ureter cancer


subject: CHEBI:175901

object_name: ureter carcinoma


subject: CHEBI:175901

object_name: renal pelvis carcinoma


subject: CHEBI:175901

object_name: malignant renal pelvis neoplasm


subject: UMLS:C0962969

subject_name: RAD 001


subject: UMLS:C0962969


subject: UMLS:C0962969

object_name: bladder tumor


subject: UMLS:C0962969

object_name: urinary bladder carcinoma


subject: UMLS:C0962969

object_name: urinary bladder cancer


subject: UMLS:C0962969

object_name: childhood bladder carcinoma


subject: UMLS:C0962969


subject: UMLS:C0962969


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: UMLS:C5198617

object_name: Congenital IGHD


subject: UMLS:C5198617

object_name: Reduced circulating growth hormone concentration


subject: UMLS:C3896879

subject_name: MYC-targeting siRNA DCR-MYC

object_name: plasma cell myeloma


subject: UMLS:C3896879

object_name: Solid Neoplasm


subject: UMLS:C3896879

object_name: non-Hodgkin lymphoma


subject: UMLS:C3896879

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C3896879

object_name: Lymphoma, Large-Cell, Follicular


subject: UMLS:C3896879

object_name: primitive neuroectodermal tumor


subject: UMLS:C3896879

object_name: Neuroendocrine tumor of pancreas


subject: UMLS:C3896879

object_name: peripheral primitive neuroectodermal tumor


subject: GTOPDB:8313

subject_name: talazoparib

object_name: Locally Advanced Ovarian Carcinoma


subject: GTOPDB:8313

object_name: Locally Advanced Prostate Carcinoma


subject: GTOPDB:8313

object_name: Locally Advanced Breast Carcinoma


subject: GTOPDB:8313

object_name: Locally Advanced Malignant Solid Neoplasm


subject: GTOPDB:8313

object_name: Locally Advanced Pancreatic Carcinoma


subject: GTOPDB:8313

object_name: Locally Advanced Gastric Carcinoma


subject: GTOPDB:8313

object_name: Stage III Ovarian Cancer AJCC v8


subject: GTOPDB:8313

object_name: Stage II Pancreatic Cancer AJCC v8


subject: GTOPDB:8313

object_name: Stage IV Ovarian Cancer AJCC v8


subject: GTOPDB:8313

object_name: Stage III Pancreatic Cancer AJCC v8


subject: GTOPDB:8313

object_name: Stage III Prostate Cancer AJCC v8


subject: GTOPDB:8313

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: GTOPDB:8313

object_name: Stage IV Prostate Cancer AJCC v8


subject: GTOPDB:8313

object_name: Clinical Stage III Gastric Cancer AJCC v8


subject: GTOPDB:8313

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: GTOPDB:8313

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: GTOPDB:8313

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: GTOPDB:8313

object_name: Pancreatic carcinoma recurrent


subject: GTOPDB:8313

object_name: Metastatic Malignant Solid Neoplasm


subject: GTOPDB:8313

object_name: Prostate cancer recurrent


subject: GTOPDB:8313

object_name: Platinum-Sensitive Ovarian Carcinoma


subject: GTOPDB:8313

object_name: Recurrent ovarian cancer


subject: GTOPDB:8313

object_name: stage IV pancreatic cancer


subject: GTOPDB:8313

object_name: recurrent gastric cancer


subject: GTOPDB:8313

object_name: Breast cancer recurrent


subject: GTOPDB:8313

object_name: Metastatic Gastric Carcinoma


subject: GTOPDB:8313

object_name: Metastatic Breast Carcinoma


subject: GTOPDB:8313

object_name: HER2 positive breast carcinoma


subject: UNII:TYH386V3WJ

subject_name: Seclidemstat

object_name: Sclerosing Epithelioid Fibrosarcoma


subject: UNII:TYH386V3WJ

object_name: Childhood Desmoplastic Small Round Cell Tumor


subject: UNII:TYH386V3WJ

object_name: desmoplastic small round cell tumor


subject: UNII:TYH386V3WJ

object_name: Adult Desmoplastic Small Round Cell Tumor


subject: UNII:TYH386V3WJ

object_name: adult myxoid chondrosarcoma


subject: UNII:TYH386V3WJ

object_name: extraskeletal myxoid chondrosarcoma


subject: UNII:TYH386V3WJ

object_name: low grade fibromyxoid sarcoma


subject: UNII:TYH386V3WJ

object_name: histiocytoma, Angiomatoid fibrous


subject: UNII:TYH386V3WJ

object_name: myoepithelioma


subject: UNII:TYH386V3WJ

object_name: myxoid liposarcoma


subject: UNII:TYH386V3WJ

object_name: myxoid/round cell liposarcoma


subject: UNII:TYH386V3WJ

object_name: clear cell sarcoma


subject: UNII:TYH386V3WJ

object_name: Ewing sarcoma


subject: CHEBI:90225

subject_name: Rubitecan

object_name: lung cancer


subject: CHEBI:90225

object_name: lung neoplasm


subject: CHEBI:90225

object_name: lung carcinoma


subject: CHEBI:94366

subject_name: itraconazole


subject: CHEBI:94366


subject: CHEBI:94366


subject: CHEBI:78538

object_name: Greater trochanteric pain syndrome


subject: UMLS:C0051846

subject_name: angiopeptin

object_name: acromegaly


subject: UMLS:C0051846

object_name: Acral overgrowth


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: Lytic lesion


subject: UMLS:C1530450

subject_name: AMG 162


subject: CHEBI:60802

subject_name: ropivacaine

object_name: colorectal cancer


subject: CHEBI:60802

object_name: colorectal carcinoma


subject: CHEBI:60802

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5238974

object_name: small cell lung carcinoma


subject: UNII:MNZ4OP95CF

subject_name: Senaparib


subject: PUBCHEM.COMPOUND:74821141

subject_name: Plazomicin

object_name: Complicated urinary tract infection


subject: PUBCHEM.COMPOUND:74821141

object_name: acute pyelonephritis


subject: CHEBI:233331

subject_name: Elamipretide

object_name: Friedreich ataxia


subject: CHEBI:233331

object_name: Friedreich ataxia 1


subject: UMLS:C4279623


subject: UMLS:C4279623


subject: UNII:M6U7MLY4HJ

object_name: neuroendocrine neoplasm


subject: UNII:M6U7MLY4HJ

object_name: neuroendocrine carcinoma


subject: UNII:M6U7MLY4HJ

object_name: adrenal cortex carcinoma


subject: UMLS:C5907922

subject_name: Anti-DLK-1 Antibody-drug Conjugate ADCT-701


subject: UMLS:C5907922


subject: UMLS:C5907922


subject: UNII:8PX1X7UG4D

subject_name: idecabtagene vicleucel

object_name: plasma cell myeloma


subject: CHEBI:41060

subject_name: IBANDRONATE

object_name: hip; necrosis


subject: CHEBI:41060

object_name: Osteonecrosis of hip


subject: UNII:UMD7G2653W

subject_name: Ibandronate


subject: UNII:UMD7G2653W


subject: MESH:C519271

subject_name: bivatuzumab mertansine

object_name: breast neoplasm


subject: CHEBI:3892

subject_name: Corticotropin

object_name: acute respiratory distress syndrome


subject: CHEBI:3892

object_name: adult acute respiratory distress syndrome


subject: UMLS:C5201181

subject_name: H.P. acthar gel


subject: UMLS:C5201181


subject: UMLS:C5222496

subject_name: Repository Corticotropin Injection


subject: UMLS:C5222496


subject: UMLS:C1176237

subject_name: Exubera

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:134517711

subject_name: soquelitinib

object_name: autoimmune lymphoproliferative syndrome type 1


subject: PUBCHEM.COMPOUND:134517711

object_name: autoimmune lymphoproliferative syndrome


subject: UNII:6I5H17AN3I

subject_name: SOQUELITINIB


subject: UNII:6I5H17AN3I


subject: CHEBI:91450

subject_name: Sapanisertib


subject: PUBCHEM.COMPOUND:23144079

subject_name: Milataxel

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:23144079

object_name: lung neoplasm


subject: UMLS:C5815598

subject_name: TransCon CNP

object_name: achondroplasia


subject: DRUGBANK:DB17824


subject: CHEMBL.COMPOUND:CHEMBL2108463

subject_name: GARLIC

object_name: Intestinal bacteria flora disturbance


subject: UMLS:C0885057

subject_name: garlic preparation


subject: CHEBI:135285

subject_name: Vildagliptin

object_name: Diabetes


subject: CHEBI:135285

object_name: Disorder related to renal transplantation


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381

object_name: Klatskin Tumor


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:39867

subject_name: Valproic acid


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: atrial fibrillation


subject: UNII:C8ADC441ME

object_name: Atrial Fibrillation by ECG Finding


subject: UNII:C8ADC441ME

object_name: Atrial Fibrillation, CTCAE


subject: UNII:C8ADC441ME

object_name: heart disorder


subject: UNII:59LD48P07K

object_name: hepatitis C


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: rotator cuff syndrome


subject: CHEBI:3215

object_name: Rotator cuff tear


subject: DRUGBANK:DB10982

subject_name: Sage

object_name: Alzheimer disease type 1


subject: DRUGBANK:DB10982

object_name: Alzheimer disease


subject: UMLS:C1446825

subject_name: Salvia officinalis antigen


subject: UMLS:C1446825


subject: UMLS:C3668955

subject_name: Salvia officinalis whole extract


subject: UMLS:C3668955


subject: DRUGBANK:DB11199

subject_name: Sage oil


subject: DRUGBANK:DB11199


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: post operative nausea and vomiting


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: GTOPDB:8313

subject_name: talazoparib

object_name: cancer


subject: GTOPDB:8313

object_name: neoplasm


subject: UMLS:C4725827

subject_name: Selective Estrogen Receptor Degrader G1T48

object_name: Childhood Breast Carcinoma


subject: UMLS:C4725827

object_name: breast carcinoma


subject: UMLS:C4725827

object_name: breast cancer


subject: UMLS:C4725827

object_name: Advanced breast cancer


subject: UMLS:C4725827

object_name: Carcinoma breast stage IV


subject: UMLS:C4725827

object_name: Malignant neoplasm of female breast


subject: UMLS:C4725827

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C4725827

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C4725827

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C4725827

object_name: breast neoplasm


subject: UMLS:C4725827

object_name: invasive ductal breast carcinoma


subject: UMLS:C4725827

object_name: breast ductal adenocarcinoma


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: UMLS:C0796473

object_name: leukemia


subject: UMLS:C0796473

object_name: childhood leukemia


subject: UMLS:C0796473

object_name: adult lymphoma


subject: UMLS:C0796473

object_name: lymphoma


subject: UMLS:C0796473

object_name: pediatric lymphoma


subject: UNII:73B0K5S26A

subject_name: Belimumab

object_name: membranous glomerulonephritis


subject: UNII:73B0K5S26A


subject: CHEBI:74947

subject_name: Thalidomide

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C1443151

subject_name: Gum arabic antigen

object_name: rheumatoid arthritis


subject: MESH:D006170

subject_name: Gum Arabic


subject: UNII:1YTW0422YU

subject_name: Gum arabic


subject: UMLS:C2093618

subject_name: arabic gum allergenic extract


subject: DRUGBANK:DB10451

subject_name: Acacia


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: hepatitis B


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1251704

subject_name: Lidocaine Patch

object_name: cesarean section; complications


subject: UNII:8R4A7GDZ1D

subject_name: Apabetalone

object_name: pulmonary hypertension, primary, 1


subject: UNII:8R4A7GDZ1D

object_name: pulmonary hypertension


subject: UNII:8R4A7GDZ1D

object_name: idiopathic pulmonary arterial hypertension


subject: UNII:8R4A7GDZ1D

object_name: pulmonary arterial hypertension


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib

object_name: pediatric osteosarcoma


subject: UNII:B2K5L1L8S9

object_name: Osteosarcoma


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: small cell lung carcinoma


subject: PUBCHEM.COMPOUND:73005958

object_name: non-small cell lung carcinoma


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: heart valve disorder


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: Platelet dysfunction


subject: UMLS:C1138321

subject_name: glutoxim


subject: CHEBI:39548

object_name: asthma


subject: CHEBI:39548

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:39548

object_name: COPD, severe early onset


subject: CHEBI:39548

object_name: chronic obstructive pulmonary disease


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: Advanced Gastroesophageal Junction Adenocarcinoma


subject: GTOPDB:9592

subject_name: tislelizumab


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: PR:000013574

subject_name: sulfhydryl oxidase 1


subject: MESH:C079198

subject_name: S 1 (combination)


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: retinoblastoma


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:32133

object_name: Acute Ischemic Stroke


subject: CHEBI:32133

object_name: Ischemic stroke


subject: UNII:0CLL4232KD

subject_name: SIVELESTAT SODIUM


subject: UNII:0CLL4232KD


subject: UMLS:C2699305

subject_name: Sivelestat Sodium


subject: UMLS:C2699305


subject: UMLS:C0286078

subject_name: Vistide

object_name: cervical cancer


subject: UMLS:C0286078

object_name: cervical carcinoma


subject: CHEBI:3696

subject_name: Cidofovir


subject: CHEBI:3696


subject: GTOPDB:12990

subject_name: sintilimab

object_name: gastric adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UMLS:C0962969

subject_name: RAD 001

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Stage IA Cervical Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage I Cervical Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:9995208

subject_name: Estetrol

object_name: Uses contraception (finding)


subject: CHEBI:33472

subject_name: diphosphorus


subject: UMLS:C1384585

subject_name: Blood group antigen P2


subject: PR:000012849

subject_name: biogenesis of lysosome-related organelles complex 1 subunit 6


subject: UMLS:C2607565

object_name: neuralgia


subject: UMLS:C2607565

object_name: Neuralgia, CTCAE


subject: UMLS:C2607565

object_name: peripheral nervous system disorder


subject: UMLS:C2607565

object_name: herpes zoster


subject: UMLS:C2607565

object_name: Shingles, CTCAE


subject: CHEBI:23359

subject_name: colchicine


subject: CHEBI:23359

object_name: transient ischemic attack


subject: CHEBI:23359

object_name: punctate palmoplantar keratoderma type III


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: refractory malignant neoplasm


subject: UNII:28X28X9OKV

object_name: colorectal adenocarcinoma


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C4722744

subject_name: Pexa-vec

object_name: colorectal cancer


subject: UMLS:C4722744

object_name: colorectal carcinoma


subject: UMLS:C4722744

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4722744


subject: UMLS:C4722744

object_name: colorectal neoplasm


subject: UMLS:C4722744


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: GTOPDB:12990


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335


subject: CHEBI:71954

subject_name: Buparlisib

object_name: glioblastoma


subject: CHEBI:71954

object_name: Childhood Glioblastoma


subject: CHEBI:71954

object_name: adult glioblastoma


subject: CHEBI:4445

subject_name: Desflurane

object_name: Emergence Delirium


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Heart failure with reduced ejection fraction


subject: UMLS:C3529192

object_name: heart failure


subject: UMLS:C3529192

object_name: Heart Failure, CTCAE


subject: CHEBI:50777

subject_name: Etonogestrel

object_name: HIV-1 infection


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: Helicobacter pylori infectious disease


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Deep vein thrombosis of lower limb


subject: CHEBI:68579

object_name: Deep venous thrombosis


subject: CHEBI:73895

subject_name: Gly-D-Ser

object_name: biliary tract cancer


subject: CHEBI:73895

object_name: liver carcinoma


subject: CHEBI:73516

subject_name: Gly-Ser


subject: CHEBI:73516


subject: PR:000008058

subject_name: glutamine synthetase


subject: PR:000008058


subject: GTOPDB:12989

subject_name: toripalimab


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEBI:28171

object_name: spinal cord injury


subject: UMLS:C1880230

subject_name: 5-hydroxytryptophan, DL-


subject: CHEBI:17780

subject_name: Oxitriptan


subject: CHEBI:15765

subject_name: Levodopa


subject: CHEBI:27732

subject_name: Caffeine

object_name: mood (physical finding)


subject: CHEBI:18145

subject_name: Vitamin E

object_name: Caffeine-related disorder


subject: CHEBI:18145


subject: UMLS:C3540032

subject_name: Vitamin IV solution additives


subject: UMLS:C3540032


subject: UMLS:C3714649

subject_name: VITAMINS [VA Class]


subject: UMLS:C3714649


subject: CHEBI:46662

subject_name: mineral


subject: CHEBI:46662


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: rheumatoid arthritis


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:33330

subject_name: scandium atom


subject: PR:000007182

subject_name: erythroid membrane-associated protein


subject: PR:000050188

subject_name: polymeric immunoglobulin receptor secretory component


subject: MESH:C000611825

subject_name: Ocoxin

object_name: Surgical Complication


subject: MESH:C000611825

object_name: Post-Operative Pain


subject: MESH:C000611825

object_name: Pulmonary compliance


subject: CHEBI:63632

subject_name: Topotecan

object_name: Solid Neoplasm


subject: CHEBI:71219

subject_name: Pazopanib


subject: UMLS:C4045611

object_name: peripheral vascular disease


subject: UMLS:C4045611

object_name: peripheral arterial disease


subject: CHEMBL.COMPOUND:CHEMBL4650470

subject_name: EFPEGLENATIDE

object_name: type 2 diabetes mellitus


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Effects of chemotherapy


subject: UMLS:C2346820


subject: PR:000013574

subject_name: sulfhydryl oxidase 1


subject: CHEBI:29228

subject_name: FLUORIDE

object_name: dental caries


subject: CHEBI:29228

object_name: Dental Caries, CTCAE


subject: CHEBI:17051

subject_name: Fluoride ion


subject: CHEBI:17051


subject: UMLS:C3541971

subject_name: Fluoride supplements


subject: UMLS:C3541971


subject: UMLS:C3714616

subject_name: Fluoride Drug Class


subject: UMLS:C3714616


subject: DRUGBANK:DB17743

subject_name: Fecal microbiota

object_name: Chronic Insomnia


subject: DRUGBANK:DB17743

object_name: sleep disorder


subject: DRUGBANK:DB17743

object_name: Cognitive impairment


subject: DRUGBANK:DB17743

object_name: Depressed mood


subject: DRUGBANK:DB17743

object_name: Cancer patients and suicide and depression


subject: DRUGBANK:DB17743

object_name: Depressed - symptom


subject: DRUGBANK:DB17743

object_name: Depression, CTCAE


subject: DRUGBANK:DB17743

object_name: anxiety


subject: DRUGBANK:DB17743

object_name: anxiety disorder


subject: DRUGBANK:DB17743

object_name: Anxiety symptoms


subject: DRUGBANK:DB17743

object_name: Anxiety, CTCAE 3.0


subject: DRUGBANK:DB17743

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:52717

subject_name: Bortezomib

object_name: adult acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: multiple organ dysfunction syndrome


subject: PUBCHEM.COMPOUND:435949

object_name: acute kidney failure


subject: PUBCHEM.COMPOUND:435949

object_name: cytomegalovirus infection


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:74327


subject: CHEBI:74327


subject: CHEBI:465284

subject_name: Ganciclovir


subject: CHEBI:465284


subject: CHEBI:52214

subject_name: ligand

object_name: Transformed migraine


subject: CHEBI:52214

object_name: migraine


subject: CHEBI:52214

object_name: Episodic migraine


subject: UMLS:C0023688

subject_name: Ligands


subject: UMLS:C0023688


subject: UMLS:C0023688


subject: UMLS:C0597357

subject_name: receptor


subject: UMLS:C0597357


subject: UMLS:C0597357


subject: CHEBI:71954

subject_name: Buparlisib

object_name: endometrial cancer


subject: CHEBI:71954

object_name: uterine corpus cancer


subject: CHEBI:71954

object_name: endometrial carcinoma